Posted in | News | Gold | Mining Business

Galantas Gold Intends to Bulk Sample Kearney Stringer Vein at Omagh Gold Property

Galantas Gold Corporation (the Company or Galantas) intends, via a Northern Ireland subsidiary, to bulk sample the Kearney stringer vein on its Omagh gold property.

Grab samples earlier reported (7th September 2016) from the stringer vein ranged from 52.9g/t gold to 6.2 g/t gold. The bulk sampling operation is designed to comprehensively assess the length, width and gold grade of the gold stringer at surface and it is expected to extract the sample and restore the surface within a four month period.

Drill core H159 (reported 24th August 2016) intersected 1 metre of mineralisation grading 5.7g/t gold and 6.2g/t silver, some 50 metres vertically below the earlier reported grab samples and 11 metres south from the planned underground development decline.

The bulk sample material will be assessed within the existing processing plant to provide data to assist the determination of commerciality of underground mining of the stringer vein. The processing of ore earlier in the development program than previously considered may have positive cash flow implications.

Further to the Company's announcement on 29th September 2016, Galantas has been advised that the Judicial Review of its planning consent has been listed for continuation of the hearing on 6th, 7th and 8th December 2016.

The Company notifies a change of address for the Registered Office in Canada. Effective immediately, the new address is :-
c/o DSA Corporate Services Inc, 82 Richmond Street East, Toronto, Ontario, Canada M5C 1P1.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.